GLOBUS MEDICAL, INC. (GMED)

Every figure this model derived for GMED, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 154,797,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 595,142,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,215,512,000 AssetsCurrent 2026-06-30
current liabilities 479,347,000 LiabilitiesCurrent 2026-06-30
equity 4,768,603,000 StockholdersEquity 2026-06-30
ocf 910,387,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,144,934,000 Revenues 2026-06-30
sbc 48,956,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up GMED on one particular measure came for.

RatioValue
cash operating margin30.79
current ratio4.91
current ratio reported4.62
deferred revenue growth-12.19
dilution pct-0.59
ebit cagr34.32
ebit yoy127.2
fcf margin24.03
growth cv0.67
operating margin20.34
owner earnings margin22.47
revenue growth19.74
revenue growth per share20.45
roic12.1
rule of 4040.08
sbc pct revenue1.56

What to be careful about

What this model itself distrusts about GMED's figures. Written by the derivation as it ran, not added afterwards.